UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Lantz Financial LLC

Lantz Financial LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 9.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 985 shares of the healthcare conglomerate’s stock after selling 104 shares during the period. Lantz Financial LLC’s holdings in UnitedHealth Group were worth $498,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Linden Thomas Advisory Services LLC boosted its position in shares of UnitedHealth Group by 13.7% in the 4th quarter. Linden Thomas Advisory Services LLC now owns 4,297 shares of the healthcare conglomerate’s stock valued at $2,174,000 after purchasing an additional 518 shares during the period. Cyndeo Wealth Partners LLC boosted its position in UnitedHealth Group by 4.4% during the 4th quarter. Cyndeo Wealth Partners LLC now owns 30,115 shares of the healthcare conglomerate’s stock worth $15,234,000 after acquiring an additional 1,273 shares during the period. Geneos Wealth Management Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth about $6,922,000. Fifth Third Bancorp lifted its holdings in shares of UnitedHealth Group by 0.4% during the 4th quarter. Fifth Third Bancorp now owns 476,285 shares of the healthcare conglomerate’s stock valued at $240,934,000 after buying an additional 1,907 shares during the last quarter. Finally, Chemung Canal Trust Co. lifted its holdings in shares of UnitedHealth Group by 78.9% during the 4th quarter. Chemung Canal Trust Co. now owns 9,266 shares of the healthcare conglomerate’s stock valued at $4,687,000 after buying an additional 4,086 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. TD Cowen raised their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $627.74.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $532.26 on Friday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The firm has a market capitalization of $489.83 billion, a PE ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The business’s 50 day moving average is $541.04 and its 200-day moving average is $563.84. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the business posted $5.83 earnings per share. The business’s revenue was up 6.8% compared to the same quarter last year. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.19%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.